Screening for factor V leiden mutation before prescribing combination oral contraceptives-Reference-Cited by-同舟云学术

Screening for factor V leiden mutation before prescribing combination oral contraceptives

Published:1999-10 Issue:4 Volume:72 Page:646-651
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Creinin Mitchell D.,Lisman Rachel,Strickler Ronald C.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference30 articles.

1. FDA Talk Paper. Oral Contraceptives and Risk of Blood Clots. Nov. 14, 1995. Available at http://www.fda.gov/bbs/topics/ANSWERS/ANS00694.html. Accessed on July 16, 1998.

2. Unintended pregnancy in the United States;Henshaw;Fam Plann Perspect,1998

3. Trends in contraceptive use in the United States;Piccinino;Fam Plann Perspect,1998

4. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease;Lancet,1995

5. Risk of idiopathic cardiovascular death and non-fatal thromboembolism in women using oral contraceptives with different progestogen components;Jick;Lancet,1995

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appraising screening, making risk in/visible. The medical debate over Non‐Rare Thrombophilia (NRT) testing before prescribing the pill;Sociology of Health & Illness;2021-07-22

2. Thrombophilia screening revisited: an issue of personalized medicine;Journal of Thrombosis and Thrombolysis;2020-04-04

3. Contraception for Women with Medical Conditions;The Handbook of Contraception;2020

4. Re-Examining Genetic Screening and Oral Contraceptives: A Patient-Centered Review;Journal of Personalized Medicine;2019-01-15

5. Thrombophilia;Consultative Hemostasis and Thrombosis;2019